A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
Anne Campbell, an R&D associate in ORNL’s Materials Science and Technology Division since 2016, has been selected as an associate editor of the Journal of Nuclear Materials.